COMPARISON OF TOXICITY OF MITOZANTRONE AND DOXORUBICIN WHEN USED IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE FOR ADVANCED BREAST-CANCER

被引：0
作者：
HALL, VL [1 ]
BUCHANAN, RB [1 ]
WILLIAMS, CJ [1 ]
机构：
[1] ROYAL S HANTS HOSP,COMBINED BREAST CLIN,SOUTHAMPTON SO9 4PE,HANTS,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1988年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：263 / 263
页数：1
相关论文
共 50 条
  • [21] L-PHENYLALANINE MUSTARD, DOXORUBICIN, AND VINCRISTINE IN ADVANCED BREAST-CANCER - A PILOT-STUDY
    TORMEY, DC
    BULL, JM
    LIPPMAN, ML
    CANCER TREATMENT REPORTS, 1980, 64 (8-9): : 1015 - 1016
  • [22] ALTERNATIVE ADMINISTRATION OF EPIRUBICIN, VINCRISTINE AND MITOXANTRONE, VINCRISTINE IN ADVANCED BREAST-CANCER
    KOSMIDIS, PA
    FOUNTZILAS, G
    TSAVARIS, N
    KALOGERA, A
    KARABELIS, A
    BACOYIANNIS, C
    KARVOUNIS, N
    MILONAKIS, N
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1990, 9 (04) : 215 - 219
  • [23] A PROSPECTIVE RANDOMIZED COMPARISON OF EPIRUBICIN AND DOXORUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER
    JAIN, KK
    CASPER, ES
    GELLER, NL
    HAKES, TB
    KAUFMAN, RJ
    CURRIE, V
    SCHWARTZ, W
    CASSIDY, C
    PETRONI, GR
    YOUNG, CW
    WITTES, RE
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) : 818 - 826
  • [24] A PHASE-II TRIAL OF CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, AND PREDNISOLONE RAPIDLY ALTERNATING WITH DOXORUBICIN AND VINCRISTINE (CMFP/AV) IN ADVANCED BREAST-CANCER
    RISCHIN, D
    BISHOP, JF
    OLVER, IN
    LAIDLAW, CR
    ZIMET, A
    JEAL, P
    DIPELL, JF
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (05): : 392 - 394
  • [25] A COMPARISON OF MITOXANTRONE AND DOXORUBICIN IN BREAST-CANCER
    NEIDHART, JA
    GOCHNOUR, D
    ROACH, R
    HOTH, D
    YOUNG, D
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) : 672 - 677
  • [26] Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer
    Kenji Katsumata
    Hidenori Tomioka
    Mikihiro Kusama
    Tatsuya Aoki
    Yasuhisa Koyanagi
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 86 - 88
  • [27] PRIMARY ENDOCRINE THERAPY AND PREDNISOLONE IN ADVANCED BREAST-CANCER
    RUBENS, RD
    STEWART, JF
    KING, RJB
    MINTON, MJ
    SPARROW, GEA
    KNIGHT, RK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 436 - 436
  • [28] Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer
    Katsumata, K
    Tomioka, H
    Kusama, M
    Aoki, T
    Koyanagi, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (01) : 86 - 88
  • [29] ADJUVANT CHEMOTHERAPY OF BREAST-CANCER WITH VINCRISTINE, DOXORUBICIN AND CYCLOPHOSPHAMIDE +/- TAMOXIFEN + RADIOTHERAPY
    RAINEY, JM
    MEZA, LA
    TRAUTH, CJ
    KUEBLER, W
    BURROUGHS, R
    FARUQUI, S
    PRADOS, M
    MARTIN, JD
    CLINICAL RESEARCH, 1981, 29 (05): : A843 - A843
  • [30] Mitomycin C, methotrexate, and vincristine with medroxyprogesterone acetate or prednisolone for doxorubicin resistant advanced breast cancer - A randomized control study
    Tashiro, H
    Nomura, Y
    ANTICANCER RESEARCH, 1995, 15 (5B) : 2229 - 2237
12345